Bares Capital Management’s Health Catalyst HCAT Stock Holding History

Bares Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-450,000	Closed	-$3.39M	–	30
2024 Q1	$3.39M	Hold	450,000	–	–	0.13%	31
2023 Q4	$4.17M	Sell	450,000 -250,000	-36%	-$2.04M	0.16%	32
2023 Q3	$7.08M	Sell	700,000 -80,000	-10%	-$955K	0.3%	34
2023 Q2	$9.75M	Buy	780,000 +330,000	+73%	+$3.93M	0.34%	34
2023 Q1	$5.25M	Sell	450,000 -2,400	-0.5%	-$30.6K	0.19%	39
2022 Q4	$4.81M	Hold	452,400	–	–	0.18%	36
2022 Q3	$4.39M	Buy	452,400 +200,000	+79%	+$2.65M	0.17%	37
2022 Q2	$3.66M	Buy	252,400 +9,553	+4%	+$163K	0.13%	35
2022 Q1	$6.35M	Buy	242,847 +103,542	+74%	+$2.94M	0.15%	35
2021 Q4	$5.52M	Hold	139,305	–	–	0.11%	34
2021 Q3	$6.97M	Buy	+139,305	New	+$7.6M	0.13%	34

Other funds holding HCAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bares Capital Management's HCAT Position: Q2 2024 in Review

Bares Capital Management sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 450,000 shares — an estimated $3.39M sold.

Bares Capital Management first reported a position in HCAT in Q3 2021 and held it in 11 quarters. The position peaked at $9.75M in Q2 2023. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

Bares Capital Management reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
Bares Capital Management sold 450,000 Health Catalyst shares in Q2 2024, an estimated $3.39M.
Bares Capital Management first reported a position in Health Catalyst in Q3 2021 and held it in 11 quarters.
Bares Capital Management's Health Catalyst position peaked at $9.75M in Q2 2023.
161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on Bares Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.